Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $434.26 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $121.84 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $106.58 | 4 | $0 (2024) |
| AbbVie Inc. | $97.99 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $41.30 | 2 | $0 (2024) |
| Lundbeck LLC | $19.46 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.20 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $15.71 | 1 | $0 (2024) |
| Indivior Inc. | $14.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.04 | 7 | Neurocrine Biosciences, Inc. ($64.67) |
| 2023 | $152.32 | 3 | Novo Nordisk Inc ($121.84) |
| 2022 | $41.91 | 1 | Neurocrine Biosciences, Inc. ($41.91) |
| 2021 | $97.99 | 1 | AbbVie Inc. ($97.99) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neuropsychiatry | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Neurology | ||||||
| 07/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuropsychiatry | ||||||
| 05/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Neuropsychiatry | ||||||
| 10/26/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: BH | ||||||
| 08/01/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: PSYCHIATRY | ||||||
| 05/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.84 | General |
| 01/06/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $41.91 | General |
| Category: Neuropsychiatry | ||||||
| 06/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 286 | 341 | $89,477 | $24,629 |
| 2022 | 4 | 339 | 412 | $88,023 | $28,575 |
| 2021 | 7 | 318 | 433 | $94,352 | $27,007 |
| 2020 | 11 | 392 | 642 | $131,173 | $41,381 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99325 | New patient assisted living visit, typically 30 minutes | Office | 2020 | 12 | 12 | $1,909 | $581.51 | 30.5% |
About Caroline Baker, NP
Caroline Baker, NP is a Family healthcare provider based in Upper Arlington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1558713487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caroline Baker, NP has received a total of $434.26 in payments from pharmaceutical and medical device companies, with $142.04 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($434.26).
As a Medicare-enrolled provider, Baker has provided services to 1,335 Medicare beneficiaries, totaling 1,828 services with total Medicare billing of $121,591. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Upper Arlington, OH
- Active Since 07/03/2016
- Last Updated 12/09/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1558713487
Products in Payments
- INGREZZA (Drug) $106.58
- UBRELVY (Drug) $97.99
- REXULTI (Drug) $35.76
- ABILIFY ASIMTUFII (Drug) $25.00
- CAPLYTA (Drug) $17.20
- UZEDY (Drug) $15.71
- PERSERIS (Drug) $14.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Upper Arlington
Brooke Laturell
Family — Payments: $873.90
Peter Dipiazza, Dnp, Bc-Fnp, DNP, BC-FNP
Family — Payments: $644.43
Laura Seiler, Np, NP
Family — Payments: $352.74
Taylor Hale, Np, NP
Family — Payments: $260.96
Cassandra Bernard
Family — Payments: $234.39
Amy Canini, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $211.30